Our Commitment
Corbus is committed to helping people defeat serious illness by bringing innovative scientific approaches to well-understood biological pathways.
Learn More
Our Science
Corbus’ pipeline encompasses two different approaches to oncology with different risk profiles: a next-generation Nectin -4 Antibody Drug Conjugate (ADC) and monoclonal antibodies that target integrins to inhibit activation of TGFβ.
Learn MoreJoin Our Team
We are a unique team of individuals who are high-achieving, innovative, creative, and above all else, passionate about what we do.
View All News
Recent News
Investor Information
CRBP
Nasdaq
Volume
Market Cap
Change